The aim of this virtual training is to provide participants with in-depth knowledge of RSV (Respiratory Syncytial Virus), including its genomic diversity, evolution, available treatments, and emerging vaccine strategies. The focus will be on how genomic data informs public health responses, the impact of RSV on vulnerable populations, and ongoing advancements in treatment and prevention. The training will also explore regulatory frameworks and public health strategies for managing RSV outbreaks.

Dates and duration: 10 and 13 December 2024 (Two half-days)

Audience: Public health microbiologists, epidemiologists and bioinformaticians.

Objectives: Upon completion of this workshop, participants will be able to:

• Understand the virology, epidemiology, and clinical impact of RSV on global health.
• Explain RSV genomic diversity, evolutionary trends, and their implications for public health.
• Use bioinformatics tools to analyse RSV genomic sequences, variants, and interpret phylogenetic data.
• Analyse genomic data to better understand RSV transmission patterns and outbreaks.
• Describe current RSV treatment options and advancements in monoclonal antibodies.
• Understand the status and challenges in developing RSV vaccines, particularly for vulnerable groups like pregnant women.

Participation: This course is open for public enrolment.